FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of Bio-Techne Corp common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported beneficial ownership of 1,088,114.27 shares of Bio-Techne Corp common stock.
  • Percent of class: The 1,088,114.27 shares represent 0.7% of the outstanding common stock, according to the filing.
  • Sole voting power (FMR LLC): FMR LLC reported sole voting power over 1,005,122.07 shares.
  • Sole dispositive power: FMR LLC reported sole dispositive power over 1,088,114.27 shares; Abigail P. Johnson reported the same sole dispositive power figure.
  • Shared power: Both reporting persons disclosed 0.00 shares subject to shared voting or shared dispositive power.
  • Triggering event date: The date of the event requiring this filing was September 30, 2026.
  • Ordinary course certification: The filing certifies the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

FMR LLC and Johnson Disclose Bio-Techne Position in Amended 13G

FMR LLC, a Delaware-organized holding company located at 245 Summer Street, Boston, Massachusetts 02210, filed Amendment No. 2 to a Schedule 13G covering Bio-Techne Corp (NASDAQ:TECH) common stock (CUSIP 09073M104). The filing, dated November 4, 2026, reflects a triggering event date of September 30, 2026. Bio-Techne Corp's principal executive offices are listed at 614 McKinley Place N.E., Minneapolis, MN 55413, according to the filing.

According to the filing, FMR LLC reported aggregate beneficial ownership of 1,088,114.27 shares, equal to 0.7% of the class. FMR LLC disclosed sole voting power over 1,005,122.07 shares and sole dispositive power over 1,088,114.27 shares, with no shared voting or dispositive power. Abigail P. Johnson, a United States citizen, is separately listed as a reporting person with the same aggregate beneficial ownership figure of 1,088,114.27 shares and 0.7% of class, with sole dispositive power over those shares but 0.00 sole or shared voting power attributed directly to her.

The filing notes that "one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of BIO-TECHNE CORP," but states that no single other person's interest exceeds five percent of the total outstanding common stock. FMR LLC is classified as a parent holding company (type HC) in the filing; Abigail P. Johnson is classified as an individual (type IN). The filing was signed by Stephanie J. Brown under powers of attorney granted by FMR LLC and Abigail P. Johnson.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G disclosing combined beneficial ownership of 1,088,114.27 shares, or 0.7%, of Bio-Techne Corp common stock as of September 30, 2026, with no shared voting or dispositive power reported.